Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walker & Dunlop (NY: WD )

106.62 -0.95 (-0.88%)
Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Walker & Dunlop

< Previous 1 2 3 4 5 6 7 Next >
Walker & Dunlop Leverages Advisory Experience to Help Capital Providers Manage Loan Portfolios
From Walker & Dunlop
Via Business Wire
Walker & Dunlop’s NY Capital Markets Team Closed Nearly $300 Million in December
From Walker & Dunlop
Via Business Wire
3 Stocks That Can Double in 2023 After Being Cut in Half Last Year
2022 was a rough year for these high-potential growth stocks, but they could be worth a closer look now. 
Via The Motley Fool
3 Top Stocks to Buy Before 2023
Here are some great bargains for long-term investors as we approach the end of the year. 
Via The Motley Fool
Walker & Dunlop's Return On Capital Employed Insights
Via Benzinga
Walker & Dunlop (WD) Q3 2022 Earnings Call Transcript
WD earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Recap: Walker & Dunlop Q2 Earnings
  Walker & Dunlop (NYSE:WD) reported its Q2 earnings results on Thursday, August 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Stocks to Be Thankful for and Stocks to Avoid
Plus, we talk with Scott Galloway, author of "Adrift: America in 100 Charts." 
Via The Motley Fool
This Real Estate Powerhouse Is Beginning to Look Cheap: Here's Its Long-Term Bull Case
This top multifamily lender is working to solve the affordable housing crisis. 
Via The Motley Fool
Walker & Dunlop's Ex-Dividend Date Is Wednesday, Here's What You Need To Know
Tuesday marks the last chance for investors to receive the next dividend payout from Walker & Dunlop (NYSE:WD). 
Via Benzinga
Earnings Scheduled For November 9, 2022
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million. 
Via Benzinga
Recap: Walker & Dunlop Q1 Earnings
Walker & Dunlop (NYSE:WD) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Price Over Earnings Overview: Walker & Dunlop
  
Via Benzinga
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 283 companies set new 52-week lows. 
Via Benzinga
4 Forever Stocks You Can Buy On Sale Right Now
These businesses could beat the market for decades to come. 
Via The Motley Fool
2 Growth Stocks With 115% and 154% Upside in the Bear Market, According to Wall Street
The S&P 500 and the Nasdaq Composite are in a bear market, but some Wall Street analysts remain bullish on these growth stocks. 
Via The Motley Fool
Walker & Dunlop's Return On Capital Employed Insights
According to Benzinga Pro data Walker & Dunlop (NYSE:WD) posted a 23.29% decrease in earnings from Q1. Sales, however, increased by 6.7% over the previous quarter to $340.85 million. 
Via Benzinga
Walker & Dunlop's Return On Capital Employed Insights
Pulled from Benzinga Pro data, Walker & Dunlop (NYSE:WD) posted Q1 earnings of $70.53 million, an increase from Q4 of 11.54%. Sales dropped to $319.44 million, a 21.55% decrease between quarters. 
Via Benzinga
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. 
Via Benzinga
3 Mortgage & Related Services Players Set to Brave Industry Woes
House price appreciation, rebound in the economy, and continued GDP growth are likely to drive U.S. single-family mortgage debt outstanding in the upcoming years. 
Via Talk Markets
Walker & Dunlop: Q4 Earnings Insights
  Walker & Dunlop (NYSE:WD) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
What Does Walker & Dunlop's Debt Look Like?
Shares of Walker & Dunlop (NYSE:WD) moved lower by 12.96% in the past three months. Before having a look at the importance of debt, let us look at how much debt Walker... 
Via Benzinga
EXCLUSIVE: Buying A Home Shouldn't Be Frustrating. See How Rocket Homes Is Providing A Smooth Experience For Home Buyers
Photo by Kindel Media from Pexels This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing... 
Via Benzinga
A Look Into Walker & Dunlop's Debt
Over the past three months, shares of Walker & Dunlop (NYSE:WD) increased by 31.46%. Before having a look at the importance of debt, let us look at how much debt Walker... 
Via Benzinga
Q3 Multifamily Housing Market Shaped By Higher Rents, Lower Vacancies: Report
The U.S. multifamily housing market is being shaped by rising rents, lower vacancies and increased sales volume, according to the newly published Walker & Dunlop (NYSE: WD)... 
Via Benzinga
3 Reasons Walker & Dunlop's Growth Is for Real
The multifamily lender is crushing the stock market -- and it's just getting started. 
Via The Motley Fool
1 Real Estate Stock That Can Keep Crushing It in 2022
This multifamily lender saw transaction volume in the third quarter increase 120% year over year. 
Via The Motley Fool
It's Not Too Late to Buy This Growth Stock
This company is helping solve major housing problems in the U.S. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021
Upgrades For Nektar Therapeutics (NASDAQ: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.